Second Alzheimer's drug to slow disease's progression may be approved in the US this year - Boston News, Weather, Sports

(CNN) — The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have<a class="excerpt-read-more" href="https://whdh.com/news/second-alzheimers-drug-to-slow-diseases-progression-may-be-approved-in-the-us-this-year/">Read More</a>

Related Keywords

Wisconsin ,United States ,California ,San Francisco ,Americans ,American ,Sharon Brangman ,Gil Rabinovici ,Los Angeles ,Daniel Skovronsky ,Lawrence Honig ,Nathaniel Chin ,Eric Widera ,Eli Lilly ,Joe Montminy ,University Dr ,Alzheimer Association International Conference On ,Journal Of The American Medical Association ,Columbia University Irving Medical Center ,University Of Wisconsin Dr ,Cnn ,University Of California ,Drug Administration ,Association International Conference ,American Medical Association ,Kacie Deters ,Disease Rating Scale ,Clinical Dementia Rating Sum ,Medical University ,